UNDERSTANDING NIPAH VIRUS INFECTION: ACOMPREHENSIVE OVERVIEW

Volume: 10 | Issue: 01 | Year 2024 | Subscription
International Journal of Animal Biotechnology and Applications
Received Date: 05/22/2024
Acceptance Date: 06/03/2024
Published On: 2024-10-09
First Page:
Last Page:

Journal Menu

By: Ms. Rama Danapure

Associate professor, Department of Community Health Nursing Maharishi Karve Stree Shikashan Samastha, Sitabai Nargundkar College Of Nursing For Women Nagpur.

Abstract

Nipah virus (NiV) infection is a zoonotic disease caused by the Nipah virus, primarily found in bats of the Pteropus genus. Since its identification in 1999 during an outbreak in Malaysia, NiV has emerged as a significant public health concern, particularly in Southeast Asia. This abstract provides a comprehensive overview of Nipah virus infection, covering its epidemiology, transmission, clinical manifestations, diagnosis, treatment, prevention, and global health implications. Epidemiology: Nipah virus outbreaks have been reported in various countries, including Singapore, India, Malaysia, and Bangladesh. Fruit bats serve as the natural reservoir of NiV, with transmission to humans typically occurring through the consumption of contaminated fruits or direct exposure to bat excreta. Transmission: Human-to-human transmission of the Nipah virus (NiV) primarily occurs through close contact with infected individuals or their bodily fluids. Nosocomial transmission has been documented during outbreaks, underscoring the critical need for infection control measures in healthcare settings. Clinical manifestations of NiV infection vary widely, ranging from mild febrile illness to severe respiratory and neurological complications, such as encephalitis. The case-fatality rates during outbreaks can vary widely, ranging from 40% to 100%. Diagnosis and Treatment: Diagnosing NiV infection can be difficult because its clinical symptoms are not specific. Laboratory testing, including molecular assays and serological methods, is essential for accurate
diagnosis. Currently, there are no specific antiviral treatments for NiV infection, and management mainly involves providing supportive care to alleviate symptoms and complications. Prevention and Control: Preventing Nipah virus outbreaks requires a multifaceted approach, including surveillance of bat populations, early detection of cases, rapid response to outbreaks, and implementation of infection control measures in healthcare settings. Vaccines and antiviral drugs targeting NiV are under development, offering promising avenues for future prevention and treatment efforts. Global Health Implications: Nipah virus infection poses significant challenges to global health security due to its potential for international spread and high case-fatality rates. Cooperation between nations and international organizations is crucial for the effective prevention and management of NiV outbreaks.

Keywords: Nipah virus, Zoonotic disease, Epidemiology, Transmission, Public health.

Loading

Citation:

How to cite this article: Ms. Rama Danapure, UNDERSTANDING NIPAH VIRUS INFECTION: ACOMPREHENSIVE OVERVIEW. International Journal of Animal Biotechnology and Applications. 2024; 10(01): -p.

How to cite this URL: Ms. Rama Danapure, UNDERSTANDING NIPAH VIRUS INFECTION: ACOMPREHENSIVE OVERVIEW. International Journal of Animal Biotechnology and Applications. 2024; 10(01): -p. Available from:https://journalspub.com/publication/understanding-nipah-virus-infection-acomprehensive-overview/

Refrences:

1. Chua KB, Bellini WJ, Rota PA, Harcourt BH, Tamin A, Lam SK, et al. Nipah virus: A recently emergent deadly paramyxovirus. Science. 2000;288(5470):1432-5.
2. Gurley ES, Montgomery JM, Hossain MJ, Bell M, Azad AK, Islam MR, et al. Person-to-person transmission of Nipah virus in a Bangladeshi community. Emerg Infect Dis. 2007;13(7):1031-7.
3. Nipah virus – India. Who.int. 2018. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/07-august-2018-nipah-virus-india-en
4. Harcourt BH, Tamin A, Ksiazek TG, Rollin PE, Anderson LJ, Bellini WJ, et al. Molecular characterization of Nipah virus, a newly emergent paramyxovirus. Virology. 2000;271(2):334-49.
5. Lo MK, Lowe L, Hummel KB, Sazzad HM, Gurley ES, Hossain MJ, et al. Characterization of Nipah virus from outbreaks in Bangladesh, 2008–2010. Emerg Infect Dis. 2012;18(2):248-55.
6. Ang BSP, Lim TCC, Wang L. Nipah virus infection. J Clin Microbiol. 2018;56(6):e01875-17.
7. Rahman MA, Hossain MJ, Sultana S, Homaira N, Khan SU, Rahman M, et al. Date palm sap-linked Nipah virus outbreak, Bangladesh. Emerg Infect Dis. 2012;18(2):1031-3.
8. Chadha MS, Comer JA, Lowe L, Rota PA, Rollin PE, Bellini WJ, et al. Nipah virus-associated encephalitis outbreak, Siliguri, India. Emerg Infect Dis. 2006;12(2):235-40.
9. Luby SP, Gurley ES, Hossain MJ. Transmission of human infection with Nipah virus. Clin Infect Dis. 2009;49(11):1743-8.
10. Hossain MJ, Gurley ES, Montgomery JM, Bell M, Carroll DS, Hossain MS, et al. Clinical presentation of Nipah virus infection in Bangladesh. Clin Infect Dis.2008;46(7):977-84.